- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 185
Daito Trust delivers $74m to JustCo
The co-working space provider received $50m in equity financing from Daito Trust and another $24m that will be put towards a joint venture.
Nov 28, 2019Appier caps series D at $80m
UMC Capital and the Arm-backed Hopu-Arm Innovation Fund backed enterprise AI software developer Appier in a round that almost doubled its overall funding to $162m.
Nov 27, 2019Goldman Sachs helps sit $60m in Citixsys
The retail and hospitality management platform developer raised $60m in a Goldman Sachs-led round that took its total funding to at least $105m.
Nov 27, 20192C2P clears $52m
Pan-Southeast Asia payment processing service 2C2P secured the funding having previously been backed by two subsidiaries of internet company GMO.
Nov 26, 2019Genetron gees itself up for $100m IPO
The Vcanbio-backed cancer diagnostics technology provider has filed to go public in the US having raised another $71m from investors including Alexandria Venture Investments.
Nov 22, 2019Azeria erects $42.2m series B
Azeria Therapeutics has picked up Syncona as an investor as it looks to bring its therapy for receptor-positive luminal breast cancer into the clinic.
Nov 22, 2019Juniper Square pegs $75m in series C
Property investment management platform Juniper Square, whose shareholders include LeFrak, has added $75m to its coffers thanks to a series C round led by Redpoint Ventures.
Nov 22, 2019Hongjiu hangs up series C funding
Sunshine Insurance and SF Express-backed fresh produce distributor Hongjiu Fruit has raised $71.1m in a round led by CMC Capital.
Nov 22, 2019N3twork nets $40m in series C round
Blue Planet Software has participated in a $40m series C round for mobile gaming product developer N3twork, which had secured $12m in a GV-backed round six years ago.
Nov 22, 2019Tissium grafts $42.8m
MIT-founded regenerative polymer developer Tissium will put the capital into clinical-stage development and toward regulatory clearance in multiple markets.
Nov 21, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


